Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares BAP1 loss, Active surveillance, Ipilimumab, Nivolumab and the tag subtype-page.
Shares CDKN2A/B homozygous deletion, Active surveillance, Pembrolizumab and the tag subtype-page.
Shares Ipilimumab, Nivolumab, Pembrolizumab and the tag subtype-page.
Shares Ipilimumab, Nivolumab, Pembrolizumab and the tag subtype-page.
Shares CDKN2A/B homozygous deletion, Pembrolizumab and the tag subtype-page.
Shares Ipilimumab, Nivolumab, Pembrolizumab and the tag subtype-page.
Shares Ipilimumab, Nivolumab, Pembrolizumab and the tag subtype-page.
Shares CDKN2A/B homozygous deletion and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-16. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.